PB Ratio: 1.40

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 1.40 is 17% below its estimated 5-year average of 1.68, near the low end of its estimated 5-year range (0.30–5.82).

As of 2026-10-06T14:57:54.234Z. 10.54% below its estimated 12-month average of 1.57.

MRKR PB Ratio Metrics

P/B vs. estimated history

At 1.40, P/B is below its estimated 10-year median — higher than 24% of readings in its estimated 10-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Marker Therapeutics, Inc. (MRKR)?

The P/B ratio for MRKR stock is 1.40.

Is Marker Therapeutics, Inc.'s P/B ratio high or low?

The P/B ratio of 1.40 is 17% below its estimated 5-year average of 1.68, near the low end of its estimated 5-year range (0.30–5.82).

What is the estimated TTM average P/B ratio for Marker Therapeutics, Inc. (MRKR)?

The estimated TTM average P/B ratio for MRKR stock is 1.57.

What is the estimated 3Y average P/B ratio for Marker Therapeutics, Inc. (MRKR)?

The estimated 3Y average P/B ratio for MRKR stock is 2.00.

What is the estimated 5Y average P/B ratio for Marker Therapeutics, Inc. (MRKR)?

The estimated 5Y average P/B ratio for MRKR stock is 1.68.

What is the estimated 10Y average P/B ratio for Marker Therapeutics, Inc. (MRKR)?

The estimated 10Y average P/B ratio for MRKR stock is 2.72.

Showing the most recent 260 of 2,490 data points. The chart above shows the full history.

Related Metrics